Hadassah Issues Statement in Response to District Court Decision in Texas Mifepristone Case

Monday, April 10, 2023

Media Contact
Lilly Freemyer
lillyfreemyer@rational360.com

202-669-0998

NEW YORK, NY – Hadassah National President Rhoda Smolow and Hadassah CEO Naomi Adler released the following statement today in response to the recent district court decision in Texas to repeal the approval of mifepristone:

"Judge Kacsmaryk’s decision to hold federal approval of mifepristone after years of safe use is an attack on American women and their right to health care, privacy and autonomy. Mifepristone has been safely used for over 20 years by millions of people in the US and across the world. Hadassah, The Women’s Zionist Organization of America, reaffirms its unwavering support for women’s right to full and complete access to reproductive health services and care. Hadassah will continue to fight for federal and state legislation affirming and protecting those rights."

About Hadassah, The Women’s Zionist Organization of America:

Hadassah, The Women’s Zionist Organization of America, is the largest Jewish women’s organization in the United States. With nearly 300,000 members, donors and supporters, Hadassah brings women together to effect change on such critical issues as ensuring Israel’s security, combating antisemitism and promoting women’s health care. Through its Jerusalem-based hospital system, the Hadassah Medical Organization, Hadassah helps support exemplary care for more than 1 million people every year as well as world-renowned medical research. Hadassah’s hospitals serve without regard to race, religion or nationality and in 2005 earned a Nobel Peace Prize nomination for building bridges to peace through medicine. Hadassah also supports two youth villages that set at-risk youth in Israel on the path to a successful future. Visit www.hadassah.org or follow Hadassah on Facebook, Instagram, LinkedIn, Threads and X.